Audit of the clinical use of fresh-frozen plasma in Umbria: Study design and results of the pilot phase

Blood Transfusion

Volumn 6, Issue 4, 2008, Pages 211-219

  Iorio, Alfonso ^a   Basileo, Michela ^b   Marchesini, Emanuela ^a   Palazzesi, Gian Paolo ^c   Materazzi, Mario ^c   Marchesi, Mauro ^b   Esposito, Antonella ^d   Pellegrini, Lucio ^e   Germani, Antonella ^b   Rocchetti, Lauretta ^b   Silvani, Carla Maria ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b CRCC/SIT AO di Perugia   (Italy)

^c SIT AO di Terni   (Italy)

^d SIT ASL 3 dell'Umbria   (Italy)

^e SIT ASL 1   (Italy)

Author keywords

Appropriateness; Audit; Plasma

Indexed keywords

FRESH FROZEN PLASMA;

ADULT; AGED; BLOOD CLOTTING TEST; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CONFERENCE PAPER; DATA BASE; DOSE CALCULATION; FEMALE; HUMAN; INTENSIVE CARE UNIT; INTERNATIONAL NORMALIZED RATIO; ITALY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MEDICAL RECORD; MEDICAL SOCIETY; METHODOLOGY; MORBIDITY; MORTALITY; SURGICAL WARD;

AGED; AGED, 80 AND OVER; BLOOD COMPONENT TRANSFUSION; FEMALE; HUMANS; ITALY; MALE; MEDICAL AUDIT; MIDDLE AGED; PLASMA; PRACTICE GUIDELINES AS TOPIC;

EID: 56649112764     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2008.0042-07     Document Type: Conference Paper

References (26)

1. Palo R, Capraro L, Hovilehto S, et al. Population-based audit of fresh-frozen plasma transfusion practices. Transfusion 2006; 46: 1921-5.
2. Triulzi DJ. The art of plasma transfusion therapy. Transfusion 2006; 46: 1268-70.
3. Agence Française de Sécurité Sanitaire des Produits de Santé. Transfusion de plasma frais congelé: produits, indications. Transfus Clin Biol 2002; 9: 322-32.
4. Crosby E, Ferguson D, Hume HA, et al. Guidelines for red blood cell and plasma transfusion for adult and children. Can Med Assoc J 1997; 156 (Suppl): S1-12.
5. National Health and Medical Research Council (NHMRC) ASoBTA. Clinical Practice Guidelines on the Use of Blood Components (red blood cells, platelets, fresh frozen plasma and cryoprecipitate) 2002. Available at: http://www.nhmrc.health.gov.au
6. O'Shaughnessy DF, Atterbury C, Bolton MP. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004; 126: 11-28.
7. Task Force on Blood Component Therapy. Practice Guidelines for blood component therapy: a report by the American Society of Anesthesiologists. Anesthesiology 1996; 83: 732-47.
8. Bowden R, Sayers M. The risk of trasmitting cytomegalovirus infection by fresh frozen plasma. Transfusion 1990; 30: 762-3.
9. Khan H, Belsher J, Yilmaz M, et al. Fresh frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. Chest 2007; 131: 1308-14.
10. Politis C, Kavallierou L, Hantziara S, et al. Quality and safety of fresh-frozen plasma inactivated and leucoreduced with the Theraflex methylene blue system including the Blueflex filter: 5 years' experience. Vox Sang 2007; 92: 319-26.
11. Webert KE, Blajchman MA. Transfusion-related acute lung injury. Transfus Med Rev 2003; 17: 252-62.
12. Beloeil H, Brosseau M, Benhamoud D. Transfusion of fresh frozen plasma (FFP): audit of prescriptions. Ann Fr Anesth Reanim 2001; 20: 686-92.
13. Schofield WN, Rubin GL, Dean MG. Appropriateness of platelet, fresh frozen plasma and cryoprecipitate transfusion in New South Wales public hospitals. MJA 2003; 178: 117-21.
14. Luk C, Eckert KM, Barr RM, Chin-Yee IH. Prospective audit of the use of fresh-frozen plasma, based on Canadian Medical Association transfusion guidelines. Can Med Assoc J 2002; 166: 1539-40.
15. Blumberg N, Laczin J, McMican A, et al. A critical survey of fresh-frozen plasma use. Transfusion 1986; 26: 511-3.
16. Brien WF, Butler RJ, Inwood MJ. An audit of blood component therapy in a Canadian general teaching hospital. Can Med Assoc J 1989; 140: 812-5.
17. Jones P, Jones A, Al-Ismail SS. Clinical use of FFP: results of retrospective process and outcome audit. Transfus Med 1998; 8: 37-41.
18. Mozes B, Epstein M, Bassat BI, et al. Evaluation of the appropriateness of blood product transfusion using present criteria. Transfusion 1989; 29: 473-6.
19. Kakkar N, Kaury R, Dhanoa J. Improvement in fresh frozen plasma transfusion practice: results of an outcome audit. Transfus Med 2004; 14: 231-5.
20. Yeh CJ, Wu CF, Hsu WT, et al. Transfusion audit of freshfrozen plasma in southern Taiwan. Vox Sang 2006; 91: 270-4.
21. Comitato per il buon uso del sangue. Azienda Ospedaliera di Perugia. Standard terapeutici e modalità operative per il buon uso del sangue 2002. Available at: www.ospedale.perugia.it. Accessed on line on 12 September 2007.
22. Barnette RE, Fish DJ, Eisenstaedt RS. Modification of freshfrozen plasma transfusion practices through educational intervention. Transfusion 1990; 30: 253-7.
23. Lahrmann C, Hojlund K, Kristensen T, Georgensen J. Use of fresh frozen plasma in patient treatment. Indications illustred by a literature review and a study of practice at a university hospital. Ugeskr Laeger 1996; 158: 3467-70.
24. Hui CH, Williams I, Davis K. Clinical audit of the use of fresh-frozen plasma and platelets in a tertiary teaching hospital and the impact of a new transfusion request form. Intern Med J 2005; 35: 283-8.
25. Tuckfield A, Haeusler MN, Grigg AP, Metz J. Reduction of inappropriate use of blood products by prospective monitoring of transfusion request forms. Med J Aust 1997; 167: 473-6.
26. American Society of Anesthesiologist. Practice guidelines for preoperative blood transfusion and adjuvant therapies. Anesthesiology 2006; 105: 198-208.